The reply
- PMID: 23684406
- DOI: 10.1016/j.amjmed.2012.11.016
The reply
Comment on
-
Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?Am J Med. 2012 Sep;125(9):859-68. doi: 10.1016/j.amjmed.2011.12.002. Epub 2012 Jun 27. Am J Med. 2012. PMID: 22748401 Review.
-
Prescribe escitalopram instead of citalopram.Am J Med. 2013 Jun;126(6):e21. doi: 10.1016/j.amjmed.2012.10.024. Am J Med. 2013. PMID: 23684405 No abstract available.
Similar articles
-
Prescribe escitalopram instead of citalopram.Am J Med. 2013 Jun;126(6):e21. doi: 10.1016/j.amjmed.2012.10.024. Am J Med. 2013. PMID: 23684405 No abstract available.
-
Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?Am J Med. 2012 Sep;125(9):859-68. doi: 10.1016/j.amjmed.2011.12.002. Epub 2012 Jun 27. Am J Med. 2012. PMID: 22748401 Review.
-
Citalopram, escitalopram: no more effective than other SSRIs, but more toxic.Prescrire Int. 2016 Apr;25(170):98. Prescrire Int. 2016. PMID: 27186623 No abstract available.
-
Torsade de pointes during combined treatment with risperidone and citalopram.Pharmacopsychiatry. 2007 Nov;40(6):294-5. doi: 10.1055/s-2007-992147. Pharmacopsychiatry. 2007. PMID: 18030657 No abstract available.
-
Towards limiting QT interval prolongation and arrhythmia risk in citalopram use.Cardiol J. 2014;21(5):454-7. doi: 10.5603/CJ.2014.0076. Cardiol J. 2014. PMID: 25434987 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical